358 related articles for article (PubMed ID: 10081841)
1. Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
Lingeman J; Kahnoski R; Mardis H; Goldfarb DS; Grasso M; Lacy S; Scheinman SJ; Asplin JR; Parks JH; Coe FL
J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841
[TBL] [Abstract][Full Text] [Related]
2. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
4. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
5. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
[TBL] [Abstract][Full Text] [Related]
6. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
7. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
8. Proportional reduction of urine supersaturation during nephrolithiasis treatment.
Coe FL; Wise H; Parks JH; Asplin JR
J Urol; 2001 Oct; 166(4):1247-51. PubMed ID: 11547051
[TBL] [Abstract][Full Text] [Related]
9. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
Cheungpasitporn W; Erickson SB; Rule AD; Enders F; Lieske JC
J Urol; 2016 May; 195(5):1476-1481. PubMed ID: 26598423
[TBL] [Abstract][Full Text] [Related]
12. The most important metabolic risk factors in recurrent urinary stone formers.
Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
[TBL] [Abstract][Full Text] [Related]
13. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
[TBL] [Abstract][Full Text] [Related]
14. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.
Prochaska M; Taylor E; Ferraro PM; Curhan G
J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983
[TBL] [Abstract][Full Text] [Related]
15. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
16. Supersaturation and stone composition in a network of dispersed treatment sites.
Asplin J; Parks J; Lingeman J; Kahnoski R; Mardis H; Lacey S; Goldfarb D; Grasso M; Coe F
J Urol; 1998 Jun; 159(6):1821-5. PubMed ID: 9598467
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ramadan fasting on urinary risk factors for calculus formation.
Miladipour AH; Shakhssalim N; Parvin M; Azadvari M
Iran J Kidney Dis; 2012 Jan; 6(1):33-8. PubMed ID: 22218117
[TBL] [Abstract][Full Text] [Related]
19. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
20. Essential arterial hypertension and stone disease.
Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
